Home › Grants › United States › NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical T
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
This announcement encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies.
Grant (non-repayable) Intake closed; program continues (check for next intake)
- Funder
- National Institutes of Health
Funder profile and all of its programs - Amount
- Award amounts are not published in the listing; see the official page.
- Where
- United States (federal)
- Eligibility
- Open to businesses and self-employed people. No cost sharing is required. Recurring: posted in 3 different years; this cycle has closed, watch for the next one.
- Sectors
- Business and entrepreneurship, Health and life sciences, Research and science, Technology, software and R&D
- Deadline
- Varies: check the official page for current dates
- Source
- Grants.gov XML extract (PAR-25-133)
- Last checked
- 2 November 2026
- Funder contacts
- Public organizational contacts on file Unlock full profile / Sign up
From official open data: listed in the official Grants.gov extract on 2026-11-02. The summary is from the official listing; the eligibility line is our plain-language reading of its eligibility codes. Confirm details on the official page.
Related grant lists
Business and entrepreneurship Health and life sciences Research and science Businesses and entrepreneurs United States United States (national) Federal agency
Full eligibility results and funder contacts come with Pro and Lifetime, coming soon.
Information only. GrantSift is not affiliated with any funder. A match means a program is likely eligible or worth checking, not that you will be funded. Always confirm details on the official page. Applying through official portals is free.